Skip to main content

Table 1 Results representing the annexin assay after treatment of pancreatic cancer cells with MFX/CFX

From: Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation

MIA Pa Ca-2 24 h 48 h Panc-1 24 h 48 h
0 μg/ml 5 ± 2 % 1.6 ± 0.5 % 0 μg/ml 5.2 ± 0.58 % 4.2 ± 2.7 %
MFX 100 μg/ml 4.3 ± 0.64 % 4.4 ± 0.85 % MFX 100 μg/ml 2.1 ± 2.7 % 4.6 ± 3.5 %
MFX 200 μg/ml 4.9 ± 0.6 % 5.9 ± 0.4 % MFX 200 μg/ml 3.3 ± 1.59 % 7.9 ± 1.2 %
MFX 400 μg/ml 12.8 ± 1.2 % 23.4 ± 2 % MFX 400 μg/ml 13 ± 1.15 % 16.9 ± 1.99 %
CFX 100 μg/ml 7.5 ± 0.3 % 7.9 ± 2.45 % CFX 100 μg/ml 9.2 ± 1.8 % 9.8 ± 1.5 %
CFX 200 μg/ml 13.8 ± 0.6 % 22.5 ± 2 % CFX 200 μg/ml 19 ± 3.4 % 14.6 ± 0.78 %
CFX 400 μg/ml 18.2 ± 0.2 % 40.6 ± 2.2 % CFX 400 μg/ml 20.5 ± 1.8 % 21.6 ± 1.4 %
  1. Values represent the percentage of apoptosis